CCL2 and atherosclerosis: Xu XR et al. [44] examined the effects of three months of lutein supplementation (20 mg) on early atherosclerosis, focusing on inflammation biomarkers associated with CVDs (IL-6, MCP-1) and lipid profile (LDL, TG).